Ameritas Advisory Services’s DexCom DXCM Stock Holding History

Ameritas Advisory Services’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-512	Closed	-$34.5K	–	1238
2025 Q3	$34.5K	Sell	512 -454	-47%	-$35.9K	﹤0.01%	1227
2025 Q2	$84.3K	Buy	+966	New	+$75.7K	﹤0.01%	1056
2023 Q2	–	Sell	-537	Closed	-$66.5K	–	1056
2023 Q1	$66.5K	Sell	537 -9,674	-95%	-$1.08M	﹤0.01%	1155
2022 Q4	$1.16M	Buy	+10,211	New	+$1.12M	0.05%	315

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameritas Advisory Services's DXCM Position: Q4 2025 in Review

Ameritas Advisory Services sold out of DexCom (DXCM) in Q4 2025, closing a stake of 512 shares — an estimated $34.5K sold.

Ameritas Advisory Services first reported a position in DXCM in Q4 2022 and held it in 4 quarters. The position peaked at $1.16M in Q4 2022. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Ameritas Advisory Services reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Ameritas Advisory Services sold 512 DexCom shares in Q4 2025, an estimated $34.5K.
Ameritas Advisory Services first reported a position in DexCom in Q4 2022 and held it in 4 quarters.
Ameritas Advisory Services's DexCom position peaked at $1.16M in Q4 2022.
920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.